Alan Louis Urban insider trades

Open-market stock purchases and sales by Alan Louis Urban, Chief Financial Officer at GT Biopharma, Inc, from SEC Form 4 filings since Mar 5, 2012.

Recent trades

No open-market trades in the last 12 months.

Companies traded

GTBP GT Biopharma, Inc: other filings, last Sep 4, 2025
SRAX SRAX, Inc: other filings, last Mar 14, 2023
RSSS Research Solutions, Inc: 4 buys, 11 sales, last Sep 20, 2021
DYSC Derycz Scientific Inc: other filings, last Feb 6, 2013

Get free alerts when Alan Louis Urban files a new trade →